Michael A Darwin - Net Worth and Insider Trading
Michael A Darwin Net Worth
The estimated net worth of Michael A Darwin is at least $24,719 dollars as of 2024-09-21. Michael A Darwin is the Principal Accounting Officer of BioCryst Pharmaceuticals Inc and owns about 3,048 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $24,719. Details can be seen in Michael A Darwin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael A Darwin has not made any transactions after 2008-07-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael A Darwin
Michael A Darwin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael A Darwin owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Michael A Darwin’s form 4 insider trades.
Insider Ownership Summary of Michael A Darwin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2008-07-31 | CFO |
Michael A Darwin Latest Holdings Summary
Michael A Darwin currently owns a total of 1 stock. Michael A Darwin owns 3,048 shares of BioCryst Pharmaceuticals Inc (BCRX) as of July 31, 2008, with a value of $24,719.
Latest Holdings of Michael A Darwin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2008-07-31 | 3,048 | 8.11 | 24,719 |
Holding Weightings of Michael A Darwin
Michael A Darwin Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael A Darwin has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 1,709 shares on July 31, 2008, which cost Michael A Darwin around $4,819.
Insider Trading History of Michael A Darwin
- 1
Michael A Darwin Trading Performance
GuruFocus tracks the stock performance after each of Michael A Darwin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael A Darwin is -51.81%. GuruFocus also compares Michael A Darwin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael A Darwin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael A Darwin's insider trading performs compared to the benchmark.
Performance of Michael A Darwin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.51 | | | | | |
| Relative Return to S&P 500(%) | 0.29 | | | | | |
Michael A Darwin Ownership Network
Michael A Darwin Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Michael A Darwin is the CFO of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Michael A Darwin made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net purchase of 23,000 shares made by Helen M. Thackray , a net sale of 8,689 shares made by Machelle Sanders , and a net sale of 7,866 shares made by Nancy J Hutson .
In summary, during the past 3 months, insiders sold 8,600 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 8,600 shares. During the past 18 months, 43,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 139,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Michael A Darwin Mailing Address
Above is the net worth, insider trading, and ownership report for Michael A Darwin. Currently GuruFocus does not have mailing address information for Michael A Darwin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
